How to Leverage Data from Start to Finish in Product Development

 

Never before have businesses been able to collect so much information about so many components of their operations.

Yet, what good is data if you don’t know how to leverage it and utilize it?

Steve Starner, Vice President of Integrated Factory Solutions at Hexagon, said it’s easy for departments or even companies to have too insular a view instead of drawing on how others are utilizing the information they’re gathering.

“People today often look for improvements, but those improvements are often within the typical ‘silo’ of a company, so that means within engineering or within manufacturing or within quality,” he said. “I think a lot of companies can benefit by capturing and analyzing data that streams through those kind of walls of the different departments within a company. We need to think about how data in engineering can help us in manufacturing and vice versa.”

There also can be a tendency to get to focused on one process, but Hexagon looks at the big picture to understand what metrics companies are trying to hit and what improvements can be made. Starner remembers working with an aerospace company that was looking for a metrology solution. Upon arrival, however, the team realized there was a bigger inefficiency they could fix.

“There was a manual drilling operation that was very labor intensive, very tooling intensive and prone to mistakes. As a matter of fact, that one area is what created more of their scrap than any other single process,” Starner said. “So, we changed direction on what we were focusing on away from just the metrology aspect to this area that looked a lot more fruitful from a return on investment point of view.”

While automation was difficult, Hexagon made it fit within the company’s needs and turned a $600,000 investment with a return of over two years to a $1.5 million investment with a nine-month return.

“I think we achieved, for them, something much greater than they initially started,” Starner said.

Be sure to subscribe to our industry publication for the latest news, videos, and podcasts in the Software & Technology Industry.

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More